Retatrutide

Description

Retatrutide is a synthetic peptide designed as a triple agonist of the GIP receptor (GIPR), GLP-1 receptor (GLP-1R), and glucagon receptor (GCGR). In research settings, Retatrutide is studied for its simultaneous activation of three metabolic receptor pathways and the resulting complex signaling interactions across pancreatic, hepatic, hypothalamic, and adipose tissue models.

BioRhex supplies Retatrutide as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.